FSD Pharma Inc Institutional ownership
What is the Institutional ownership of FSD Pharma Inc?
The Institutional ownership of FSD Pharma Inc is 1.30%
What is the definition of Institutional ownership?
Institutional Ownership is the amount of a company’s available stock owned by mutual or pension funds, insurance companies, investment firms, endowments or other large entities that manage funds on the behalf of others.
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
Institutional ownership of companies in the Technology sector on NASDAQ compared to FSD Pharma Inc
What does FSD Pharma Inc do?
fsd pharma inc., through its subsidiary, fv pharma inc., produces medical cannabis in canada. the company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for central nervous system disorders and autoimmune diseases of the skin, gi tract, and musculoskeletal system, such as chronic pain. fsd pharma inc. has strategic alliance agreements with scicann therapeutics inc., canntab therapeutics, and solarvest bioenergy inc. the company was founded in 1998 and is headquartered in toronto, canada.
Companies with institutional ownership similar to FSD Pharma Inc
- Digjam has Institutional ownership of 1.29%
- Digjam has Institutional ownership of 1.29%
- Telefonica S.A has Institutional ownership of 1.29%
- Clear Blue Technologies International has Institutional ownership of 1.29%
- Longevity Acquisition has Institutional ownership of 1.30%
- Greenland Technologies Corp has Institutional ownership of 1.30%
- FSD Pharma Inc has Institutional ownership of 1.30%
- Chevalier International has Institutional ownership of 1.30%
- Lippo has Institutional ownership of 1.30%
- BioSyent has Institutional ownership of 1.30%
- China Development has Institutional ownership of 1.30%
- Clear Blue Technologies International has Institutional ownership of 1.30%
- HeraMED has Institutional ownership of 1.31%